Akero Therapeutics (AKRO) Tops Q2 EPS by 4c

Akero Therapeutics (NASDAQ: AKRO) reported Q2 EPS of ($0.86), $0.04 better than the analyst estimate of ($0.90).

For earnings history and earnings-related data on Akero Therapeutics (AKRO) click here.

You May Also Be Interested In

• Venu Holding (VENU) PT Lowered to $8.70 at Freedom Broker
• TurboTenant Acquires TenantCloud, Expanding Its Property Management Solution
• Viking (VIK) call put ratio 1.7 calls to 1 put into quarter results